Re-irradiation Dose Per Fraction Recommendation
For an 18-year-old male requiring re-irradiation after approximately 60 Gy, use hypofractionated doses of 1.5-2.0 Gy per fraction, targeting a cumulative equivalent dose in 2 Gy fractions (EQD2) that respects organ-at-risk tolerances while maximizing tumor control.
Critical Context-Dependent Factors
The optimal dose per fraction depends entirely on:
- Anatomic site being re-irradiated (brain, spine, thorax, etc.)
- Time interval since initial radiation (tissue recovery capacity)
- Volume of overlap between original and re-treatment fields
- Critical organ proximity and cumulative dose already received
- Tumor histology and radiosensitivity
Site-Specific Fractionation Guidance
For Spinal Metastases Re-irradiation
Use single-fraction or hypofractionated SBRT approaches:
- Single fraction: 16-24 Gy 1
- 2 fractions: 24 Gy total 1
- 3 fractions: 24-27 Gy total 1, 2
- 5 fractions: 30-35 Gy total 1
The median 1-year local control with spine SBRT re-irradiation is 76%, with acceptable toxicity (1.2% myelopathy risk) 2. These regimens achieve biologically effective doses (BED) of 50 Gy or higher while respecting spinal cord tolerance.
For Intracranial Tumors (Gliomas) Re-irradiation
Use conventional or modest hypofractionation:
- 1.8-2.0 Gy per fraction to 30-40 Gy total is the established approach 3
- Hypofractionated schedules up to 3.0 Gy per fraction are feasible with modern image guidance 4
- Target cumulative EQD2 (α/β=2) limits: optic pathways 75-80 Gy, brainstem 85-100 Gy, normal brain 100-110 Gy 5
For recurrent gliomas, median survival exceeding one year is achievable with 30-40 Gy in hypofractionated schedules (≤4 Gy/fraction), particularly in patients with good performance status and disease-free intervals >1 year 3.
For Thoracic Tumors Re-irradiation
Hyperfractionated approach shows promise:
- 1.2 Gy twice daily to 60 Gy total (50 fractions) demonstrated favorable local control (67% at 12 months) and acceptable toxicity in a recent series 6
- This approach allows cumulative doses exceeding traditional constraints (proximal bronchial tree >110 Gy, great vessels >120 Gy) without excessive toxicity 6
- Maintain at least 6-hour interfraction interval for normal tissue repair
For Esophageal Cancer Re-irradiation
Conventional fractionation with dose escalation:
- Re-RT dose ≥50 Gy improves survival (independent prognostic factor, p=0.007) 7
- Use 1.8-2.0 Gy per fraction
- Caution with doses >60 Gy due to severe complication risk 7
Critical Dose Calculation Principles
Cumulative Dose Assessment
Convert all doses to EQD2 using linear-quadratic model:
- For late normal tissue toxicity: α/β = 2-3 Gy
- For tumor: α/β = 10 Gy
Account for tissue recovery:
Deformable dose mapping should account for anatomical changes between treatments 9
Practical Treatment Algorithm
Step 1: Determine time since initial RT
- <12 months: Consider non-RT options or palliative doses only
- 12-24 months: Conservative re-RT doses (30-40 Gy)
24 months: More aggressive re-RT feasible (40-60 Gy)
Step 2: Calculate cumulative organ-at-risk doses
- Sum EQD2 from prior treatment and planned re-RT
- Compare against site-specific tolerance limits
Step 3: Select fractionation based on site and goals
- Spine/oligometastatic disease: SBRT (high dose/fraction)
- Brain tumors: Conventional to modest hypofractionation (1.8-3.0 Gy)
- Thoracic tumors: Consider hyperfractionation (1.2 Gy BID)
- Esophagus: Conventional fractionation (1.8-2.0 Gy)
Step 4: Adjust total dose based on:
- Target volume size (smaller volumes tolerate higher doses)
- Performance status (ECOG 0-1 required for aggressive re-RT)
- Tumor histology (radiosensitive vs. radioresistant)
Common Pitfalls to Avoid
Don't use flat constraints that ignore prior radiation—always calculate cumulative doses 5
Don't assume complete tissue recovery—even with long intervals, some cumulative effect persists 5
Don't exceed 4 Gy per fraction for brain re-irradiation without stereotactic precision 3
Don't ignore volume effects—large volume re-irradiation requires more conservative fractionation 6
Don't proceed without modern imaging—deformable registration is essential for accurate dose summation 9
Quality of Life Considerations
Re-irradiation aims primarily for symptom palliation and local control rather than cure. The fractionation schedule should balance:
- Convenience (fewer fractions preferred if equivalent outcomes)
- Toxicity risk (lower per-fraction doses reduce late effects)
- Efficacy (adequate BED for tumor control)
For this 18-year-old patient, given the young age and potential for long-term survival, prioritize conventional fractionation (1.8-2.0 Gy) or modest hypofractionation (2.0-2.5 Gy) to minimize late toxicity risk, unless treating oligometastatic disease where SBRT is appropriate.